Literature DB >> 21678278

[MDR, pre-XDR and XDR drug-resistant tuberculosis in Poland in 2000-2009].

Monika Kozińska1, Anna Brzostek, Dorota Krawiecka, Małgorzata Rybczyńska, Zofia Zwolska, Ewa Augustynowicz-Kopeć.   

Abstract

INTRODUCTION: Tuberculosis (TB) is a curable disease and its spread can be prevented by using appropriate diagnostic methods and effective treatment. The obstacle to the rapid eradication of the disease from a population may be strains resistant to essential and most effective antibiotics. In many places in the world MDR, pre-XDR and XDR-TB was reported. These forms of TB do not respond to the standard six-month treatment with first-line anti-TB drugs and the therapy should be conducted two years or more with drugs that are less potent, more toxic and much more expensive.
MATERIAL AND METHODS: This study included MDR-TB strains isolated from 297 patients in 2000-2009. To determine the XDR-TB population structure, the 19 isolates were genotyped by spoligotyping and MIRU-VNTR (mycobacterial interspersed repetitive units-variable number of tandem repeats) method.
RESULTS: Among 297 MDR-TB cases, 36 (12.1%) were pre-extensively drug-resistant (pre-XDR), 19 (6.4%) were XDR and 1 (0.3%) was pre-totally drug-resistant (pre-TDR). Four of the 19 XDR isolates exhibit a unique spoligopattern, while the rest 15 belonged to one of 5 clusters. The MIRU-VNTR analysis reduced the number of clustered isolates to 11.
CONCLUSIONS: The study documented the emergence of pre-extensively and extensively drug-resistant tuberculosis in Poland among patients with multidrug-resistant TB. Genotyping methods showed clonal similarity among XDR strains and may suggest the possible transmission among patients with newly diagnosed and with recurrent TB.

Entities:  

Mesh:

Year:  2011        PMID: 21678278

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  6 in total

1.  Map the gap: missing children with drug-resistant tuberculosis.

Authors:  C M Yuen; C A Rodriguez; S Keshavjee; M C Becerra
Journal:  Public Health Action       Date:  2015-03-21

2.  Genome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug Resistance.

Authors:  Chee Sian Kuan; Chai Ling Chan; Su Mei Yew; Yue Fen Toh; Jia-Shiun Khoo; Jennifer Chong; Kok Wei Lee; Yung-Chie Tan; Wai-Yan Yee; Yun Fong Ngeow; Kee Peng Ng
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

3.  A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.

Authors:  Parul Singhal; Pratima Dixit; Pooja Singh; Indu Jaiswal; Mastan Singh; Amita Jain
Journal:  Indian J Med Res       Date:  2016-03       Impact factor: 2.375

4.  The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.

Authors:  Agumas Shibabaw; Baye Gelaw; Wondwossen Gebreyes; Richard Robinson; Shu-Hua Wang; Belay Tessema
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

5.  Tuberculosis in Poland: Epidemiological and Molecular Analysis during the COVID-19 Pandemic.

Authors:  Dagmara Borkowska-Tatar; Anna Zabost; Monika Kozińska; Ewa Augustynowicz-Kopeć
Journal:  Diagnostics (Basel)       Date:  2022-08-03

6.  Challenges and controversies in defining totally drug-resistant tuberculosis.

Authors:  Peter Cegielski; Paul Nunn; Ekaterina V Kurbatova; Karin Weyer; Tracy L Dalton; Douglas F Wares; Michael F Iademarco; Kenneth G Castro; Mario Raviglione
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.